EXV4:XETRA:XETRA-iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 118.92

Change

-0.94 (-0.78)%

Market Cap

USD 0.70B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.14 (-0.28%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.34%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.07 (-0.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.09 (-0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.04 (-0.14%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.64 (+0.45%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.13%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.42%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.21 (-0.21%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.18 (-0.03%)

USD 80.38B

ETFs Containing EXV4:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.63% 66% D+ 67% D+
Dividend Return 1.17% 40% F 26% F
Total Return 13.80% 69% C- 69% C-
Trailing 12 Months  
Capital Gain 13.39% 41% F 45% F
Dividend Return 1.42% 38% F 25% F
Total Return 14.81% 43% F 46% F
Trailing 5 Years  
Capital Gain 44.83% 62% D 65% D
Dividend Return 5.67% 63% D 34% F
Total Return 50.50% 66% D+ 65% D
Average Annual (5 Year Horizon)  
Capital Gain 6.42% N/A N/A 55% F
Dividend Return 7.35% N/A N/A 57% F
Total Return 0.94% N/A N/A 43% F
Risk Return Profile  
Volatility (Standard Deviation) 8.43% N/A N/A 73% C
Risk Adjusted Return 87.19% N/A N/A 89% A-
Market Capitalization 0.70B 71% C- 63% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike